Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Short Interest Update

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) saw a significant drop in short interest during the month of December. As of December 15th, there was short interest totaling 4,335,942 shares, a drop of 36.3% from the November 30th total of 6,810,216 shares. Based on an average daily volume of 1,818 shares, the days-to-cover ratio is currently 2,385.0 days. Based on an average daily volume of 1,818 shares, the days-to-cover ratio is currently 2,385.0 days.

Genomma Lab Internacional Price Performance

OTCMKTS:GNMLF opened at $1.06 on Friday. The company has a 50 day simple moving average of $0.98 and a two-hundred day simple moving average of $1.08. Genomma Lab Internacional has a 12 month low of $0.93 and a 12 month high of $1.43.

Genomma Lab Internacional Company Profile

Genomma Lab Internacional, SAB. de C.V. is a Mexico City–based consumer healthcare company that develops, markets and distributes over-the-counter (OTC) pharmaceuticals, personal care products and beauty solutions. Since its founding in 1996, the firm has built a diversified portfolio encompassing topical analgesics, cold and flu remedies, digestive health treatments, skin and hair care lines, and nutritional supplements. Its product mix blends proprietary brands with licensed formulas, targeting everyday wellness and self-care needs.

The company’s growth strategy hinges on intensive marketing campaigns, including television infomercials, digital advertising and direct‐to‐consumer promotions.